Literature DB >> 21397094

Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device.

Gilbert G G Donders1, Judith Berger, Hélène Heuninckx, Gert Bellen, Ann Cornelis.   

Abstract

BACKGROUND: The levonorgestrel intrauterine system (LNG-IUS) combines a uterine foreign body and the continuous release of low-dose levonorgestrel for contraception. Its influence on the rate of vulvovaginal infections and flora disturbance is insufficiently known, but important for contraceptive advice in women, especially those who develop recurrent vaginosis or Candida vulvovaginitis. STUDY
DESIGN: Slides of 286 women who had a Pap smear taken before and 1 to 2 years after placement of a LNG-IUS were blindly reviewed for the presence of abnormal vaginal flora (AVF), bacterial vaginosis (BV), aerobic vaginitis (AV) and Candida vaginitis (CV).
RESULTS: Prior to insertion, there were no differences in vaginal flora abnormalities between women using different kinds of contraception. LNG-IUS users did not have different rates of AVF, BV, AV or CV, but the general risk to develop any infection was increased. Uterine bleeding after insertion did not seem to predict a different flora type.
CONCLUSION: We found that Pap smears suggested more vaginal infections after 1 year of LNG-IUS use than prior to insertion of the device.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21397094     DOI: 10.1016/j.contraception.2010.08.007

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.

Authors:  G Donders; G Bellen; J Ausma; L Verguts; J Vaneldere; P Hinoul; M Borgers; D Janssens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-28       Impact factor: 3.267

2.  Influence of contraceptive choice on vaginal bacterial and fungal microflora.

Authors:  G Donders; G Bellen; D Janssens; B Van Bulck; P Hinoul; J Verguts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-09       Impact factor: 3.267

3.  Selecting anti-microbial treatment of aerobic vaginitis.

Authors:  Gilbert G G Donders; Katerina Ruban; Gert Bellen
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

4.  Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study.

Authors:  Tessa Madden; Jaclyn M Grentzer; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-03       Impact factor: 2.830

5.  Effects of Different Contraceptive Methods on Cervico-Vaginal Cytology.

Authors:  Khushboo Garg; Anjali Khare; Rani Bansal; Sangeeta Sharma; Neha Chaudhary
Journal:  J Clin Diagn Res       Date:  2017-07-01

6.  Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model.

Authors:  S A Hashway; I L Bergin; C M Bassis; M Uchihashi; K C Schmidt; V B Young; D M Aronoff; D L Patton; J D Bell
Journal:  J Med Primatol       Date:  2013-11-23       Impact factor: 0.667

7.  Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities.

Authors:  P Vieira-Baptista; J Lima-Silva; C Pinto; C Saldanha; J Beires; J Martinez-de-Oliveira; G Donders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-25       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.